Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, categorized as a aod 9604 peptide dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these receptors, Retatrutide reduces hunger pangs, {promotesinsulin secr